Quarterly Results Earnings per share rose 186.96% over the past year to $0.66, which beat the estimate of $0.50. Revenue of $231,200,000 higher by 34.42% from the same period last year, which missed the estimate of $232,000,000. Guidance 10x Genomics hasn't issued any revenue guidance for the time being. How To Listen To The Conference Call Date: May 13, 2021